Federal regulations that give universities much of the responsibility to police financial conflicts of interest involving biomedical researchers have “limitations,” the General Accounting Office said ...
Psyence Biomedical (NASDAQ:PBM) has been granted an extension until Dec. 31, 2024 to demonstrate compliance with all Nasdaq continued listing rules. During the Nasdaq Listing Qualifications Hearing, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback